Open Access
Treatment of immune thrombocytopenic purpura: focus on eltrombopag
Biologics: Targets & Therapy · 2009
DOI: 10.2147/btt.2009.2984 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biologics: Targets & Therapy, 2009. Verfasst von Lawrence Rice. Beteiligte Einrichtung: Weill Cornell Medical College, Methodist Hospital, Houston, Texas, USA. lrice@tmhs.org. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
autoimmune disordereltrombopagimmune thrombocytopenic purpuraserum thrombopoietin
Autor:innen und Institutionen
- Weill Cornell Medical College, Methodist Hospital, Houston, Texas, USA. lrice@tmhs.org
Zitieren
APA
Rice, L. (2009). Treatment of immune thrombocytopenic purpura: focus on eltrombopag. Biologics: Targets & Therapy. https://doi.org/10.2147/btt.2009.2984
Vancouver
Rice L. Treatment of immune thrombocytopenic purpura: focus on eltrombopag. Biologics: Targets & Therapy. 2009. doi:10.2147/btt.2009.2984
BibTeX
@article{Rice2009,
author = {Rice, Lawrence},
title = {Treatment of immune thrombocytopenic purpura: focus on eltrombopag},
journal = {Biologics: Targets & Therapy},
year = {2009},
doi = {10.2147/btt.2009.2984}
}
EUVIMED